Patients with or without the BIM deletion did not differ significantly (defined as p > 0.05) in terms of the characteristics examined, including established prognostic factors for EGFR-mutant NSCLC [38]. The gene discussed is BCL2L11; the disease is non-small cell lung carcinoma.